JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 25 No. 7 755-758
© 1984 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Allweiss, P.
Right arrow Articles by Waxman, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Allweiss, P.
Right arrow Articles by Waxman, A.

Sialadenitis following I-131 Therapy for Thyroid Carcinoma: Concise Communication

Pamela Allweiss, Glenn D. Braunstein, Alfred Katz and Alan Waxman

Cedars-Sinai Medical Center-UCLA School of Medicine, Los Angeles, California

Correspondence: For reprints contact: Glenn D. Braunstein, MD, Division of Endocrinology, Cedars-Sinai Medical Center, 8700 Beverly Blvd., Los Angeles, CA 90048.

ABSTRACT

During a 4-yr period, ten of 87 patients (11.5%) who received therapeutic doses of radioactive iodine (I-131) for thyroid carcinoma developed acute and/or chronic sialadenitis involving the parotid (five patients) or submandibular (four patients) glands, or both (one patients). Nine of the 10 patients had received prior I-131 therapy; the precipitating I-131 dose varied between 10 and 164 mCi. Onset of symptoms occurred between 1 day and 6 mo following therapy and the duration varied from 3 wk to 21/2 yr. This complication occurs more often than has been appreciated.




This article has been cited by other articles:


Home page
JNMHome page
E. B. Silberstein
Reducing the Incidence of 131I-Induced Sialadenitis: The Role of Pilocarpine
J. Nucl. Med., April 1, 2008; 49(4): 546 - 549.
[Abstract] [Full Text] [PDF]


Home page
Journal of the American Dental AssociationHome page
L. Mandel and F. Liu
Salivary Gland Injury Resulting From Exposure to Radioactive Iodine: Case Reports
J Am Dent Assoc, December 1, 2007; 138(12): 1582 - 1587.
[Abstract] [Full Text] [PDF]


Home page
Journal of the American Dental AssociationHome page
M. D. Turner and J. A. Ship
Dry Mouth and Its Effects on the Oral Health of Elderly People
J Am Dent Assoc, September 1, 2007; 138(suppl_1): 15S - 20S.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
K. Nakada, T. Ishibashi, T. Takei, K. Hirata, K. Shinohara, S. Katoh, S. Zhao, N. Tamaki, Y. Noguchi, and S. Noguchi
Does Lemon Candy Decrease Salivary Gland Damage After Radioiodine Therapy for Thyroid Cancer?
J. Nucl. Med., February 1, 2005; 46(2): 261 - 266.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
R. Solans, J.-A. Bosch, P. Galofré, F. Porta, J. Roselló, A. Selva-O’Callagan, and M. Vilardell
Salivary and Lacrimal Gland Dysfunction (Sicca Syndrome) After Radioiodine Therapy
J. Nucl. Med., May 1, 2001; 42(5): 738 - 743.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1984 by the Society of Nuclear Medicine.